{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T19:55:04Z","timestamp":1793130904033,"version":"4.5.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001704","name":"European Society of Clinical Microbiology and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001704","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.cmi.2025.04.008","type":"journal-article","created":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T17:49:37Z","timestamp":1744480177000},"page":"1263-1271","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Short vs. long antibiotic treatment for pyelonephritis and complicated urinary tract infections: a living systematic review and meta-analysis of randomized controlled trials"],"prefix":"10.1016","volume":"31","author":[{"given":"Itay","family":"Zahavi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Digbijay","family":"Kunwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judit","family":"Olchowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hagar","family":"Dallasheh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mical","family":"Paul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2025.04.008_bib1","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1001\/jamainternmed.2016.3646","article-title":"The new antibiotic mantra-\u201cShorter is better\u201d","volume":"176","author":"Spellberg","year":"2016","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.cmi.2025.04.008_bib2","doi-asserted-by":"crossref","first-page":"210","DOI":"10.7326\/M19-1509","article-title":"Duration of antibiotic therapy: Shorter is better","volume":"171","author":"Spellberg","year":"2019","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cmi.2025.04.008_bib3","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1093\/jac\/dkt177","article-title":"Duration of antibiotic treatment for acute pyelonephritis and septic urinary tract infection-- 7 days or less versus longer treatment: Systematic review and meta-analysis of randomized controlled trials","volume":"68","author":"Eliakim-Raz","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2025.04.008_bib4","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofad500.1054","article-title":"1214. Short versus long antibiotic treatment duration for febrile urinary tract infection and acute pyelonephritis: A systematic review and meta-analysis","volume":"10","author":"Schneider-Smith","year":"2023","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.cmi.2025.04.008_bib5","unstructured":"EAU Guidelines on urological infections\u2014Uroweb; n.d. https:\/\/uroweb.org\/guidelines\/urological-infections. Accessed April 1, 2025."},{"key":"10.1016\/j.cmi.2025.04.008_bib6","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1136\/bmj.319.7203.185","article-title":"Understanding controlled trials: Baseline imbalance in randomised controlled trials","volume":"319","author":"Roberts","year":"1999","journal-title":"BMJ"},{"key":"10.1016\/j.cmi.2025.04.008_bib7","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan-A web and mobile app for systematic reviews","volume":"5","author":"Ouzzani","year":"2016","journal-title":"Syst Rev"},{"key":"10.1016\/j.cmi.2025.04.008_bib8","series-title":"The AI research assistant","year":"2024"},{"key":"10.1016\/j.cmi.2025.04.008_bib9","article-title":"RoB 2: A revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.cmi.2025.04.008_bib10","series-title":"Review Manager (RevMan) [Computer program]. Version 5.4","year":"2020"},{"key":"10.1016\/j.cmi.2025.04.008_bib11","series-title":"Cochrane Handbook for Systematic Reviews of Interventions version 6.5","article-title":"Chapter 10: Chapter 10: Analysing data and undertaking meta-analyses [last updated November 2024]","author":"Deeks","year":"2024"},{"key":"10.1016\/j.cmi.2025.04.008_bib12","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jclinepi.2010.07.015","article-title":"GRADE guidelines: 3. Rating the quality of evidence","volume":"64","author":"Balshem","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.cmi.2025.04.008_bib13","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1056\/NEJMoa2404991","article-title":"Antibiotic treatment for 7 versus 14 days in patients with bloodstream infections","volume":"392","author":"Daneman","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cmi.2025.04.008_bib14","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1093\/cid\/ciad070","article-title":"Antimicrobial for 7 or 14 days for febrile urinary tract infection in men: A multicenter noninferiority double-blind, placebo-controlled, randomized clinical trial","volume":"76","author":"Lafaurie","year":"2023","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2025.04.008_bib15","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.cmi.2021.09.001","article-title":"Seven-versus 14-day course of antibiotics for the treatment of bloodstream infections by Enterobacterales: A randomized, controlled trial","volume":"28","author":"Molina","year":"2022","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2025.04.008_bib16","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1001\/jama.2020.6348","article-title":"Effect of C-reactive protein\u2013guided antibiotic treatment duration, 7-day treatment, or 14-day treatment on 30-day clinical failure rate in patients with uncomplicated Gram-negative bacteremia: A randomized clinical trial","volume":"323","author":"von Dach","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.cmi.2025.04.008_bib17","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1093\/cid\/ciy1054","article-title":"Seven versus 14 days of antibiotic therapy for uncomplicated Gram-negative bacteremia: A noninferiority randomized controlled trial","volume":"69","author":"Yahav","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2025.04.008_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0197302","article-title":"Stopping the effective non-fluoroquinolone antibiotics at day 7 vs continuing until day 14 in adults with acute pyelonephritis requiring hospitalization: A randomized non-inferiority trial","volume":"13","author":"Rudrabhatla","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.cmi.2025.04.008_bib19","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1007\/s10096-017-2951-6","article-title":"Is 5 days of oral fluoroquinolone enough for acute uncomplicated pyelonephritis? The DTP randomized trial","volume":"36","author":"Dinh","year":"2017","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.cmi.2025.04.008_bib20","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s12916-017-0835-3","article-title":"Treatment duration of febrile urinary tract infection: A pragmatic randomized, double-blind, placebo-controlled non-inferiority trial in men and women","volume":"15","author":"van Nieuwkoop","year":"2017","journal-title":"BMC Med"},{"key":"10.1016\/j.cmi.2025.04.008_bib21","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s11255-017-1507-0","volume":"49","author":"Ren","year":"2017","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.cmi.2025.04.008_bib22","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/S0140-6736(12)60608-4","article-title":"Ciprofloxacin for 7 days versus 14 days in women with acute pyelonephritis: A randomised, open-label and double-blind, placebo-controlled, non-inferiority trial","volume":"380","author":"Sandberg","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.cmi.2025.04.008_bib23","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.urology.2007.09.002","article-title":"A double-blind, randomized comparison of levofloxacin 750 mg once-daily for five days with ciprofloxacin 400\/500 mg twice-daily for 10 days for the treatment of complicated urinary tract infections and acute pyelonephritis","volume":"71","author":"Peterson","year":"2008","journal-title":"Urology"},{"key":"10.1016\/j.cmi.2025.04.008_bib24","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1185\/030079907X233340","article-title":"A trial of levofloxacin 750 mg once daily for 5 days versus ciprofloxacin 400 mg and\/or 500 mg twice daily for 10 days in the treatment of acute pyelonephritis","volume":"23","author":"Klausner","year":"2007","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.cmi.2025.04.008_bib25","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1080\/0036554021000026988","article-title":"Ciprofloxacin for 2 or 4 weeks in the treatment of febrile urinary tract infection in men: A randomized trial with a 1 year follow-up","volume":"35","author":"Ulleryd","year":"2003","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.cmi.2025.04.008_bib26","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0924-8579(95)00011-V","article-title":"A sequential study of intravenous and oral fleroxacin for 7 or 14 days in the treatment of complicated urinary tract infections","volume":"6","author":"de Gier","year":"1995","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.cmi.2025.04.008_bib27","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.0954-6820.1988.tb15899.x","article-title":"One or three weeks\u2019 treatment of acute pyelonephritis? A double-blind comparison, using a fixed combination of pivampicillin plus pivmecillinam","volume":"223","author":"Jernelius","year":"1988","journal-title":"Acta Med Scand"},{"key":"10.1016\/j.cmi.2025.04.008_bib28","series-title":"American Society for Microbiology; Abstracts of the Thirty-ninth Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA","first-page":"665","article-title":"Treatment of acute uncomplicated pyelonephritis (AUP): A randomized trial comparing 7- vs. 14-day therapy","volume":"613","author":"Mensa","year":"1999"},{"key":"10.1016\/j.cmi.2025.04.008_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2022.101750","article-title":"Duration of antibiotic treatment for Gram-negative bacteremia\u2014Systematic review and individual participant data (IPD) meta-analysis","volume":"55","author":"Turjeman","year":"2023","journal-title":"eClinicalMedicine"},{"key":"10.1016\/j.cmi.2025.04.008_bib30","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1001\/jama.2021.9899","article-title":"Effect of 7 vs 14 days of antibiotic therapy on resolution of symptoms among afebrile men with urinary tract infection: A randomized clinical trial","volume":"326","author":"Drekonja","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.cmi.2025.04.008_bib31","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1001\/jama.283.12.1583","article-title":"Comparison of ciprofloxacin (7 days) and trimethoprim-sulfamethoxazole (14 days) for acute uncomplicated pyelonephritis in women: A randomized trial","volume":"283","author":"Talan","year":"2000","journal-title":"JAMA"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X25001715?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X25001715?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T03:16:45Z","timestamp":1785554205000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X25001715"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":31,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S1198743X25001715"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2025.04.008","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Short vs. long antibiotic treatment for pyelonephritis and complicated urinary tract infections: a living systematic review and meta-analysis of randomized controlled trials","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2025.04.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}